-
DE
Rebamipide is a gastroprotective drug used to protect and heal the gastric mucosa in conditions such as peptic ulcers and gastritis. It stimulates mucus production and promotes mucosal regeneration.
Add as Preferred SourceRebamipide is a gastroprotective drug used to protect and heal the gastric mucosa in conditions such as peptic ulcers and gastritis. It stimulates mucus production and promotes mucosal regeneration.
Rebamipide is a gastroprotective agent – a compound that protects and supports the regeneration of the gastric mucosal lining. It belongs to the class of mucosal protective substances and has been used clinically for decades, primarily in Asian countries such as Japan, South Korea, and China. Scientific interest in rebamipide is also growing in Western countries.
Rebamipide is used in the treatment of:
Rebamipide exerts its protective effects through several complementary mechanisms:
The standard dosage for peptic ulcers and gastritis is 100 mg three times daily (morning, noon, and evening), typically administered as an oral tablet. The duration of treatment depends on the clinical indication and individual response, commonly ranging from 4 to 8 weeks. In cases of NSAID-induced gastropathy, rebamipide is administered concurrently with NSAID therapy as a protective measure.
Rebamipide is generally well tolerated. Possible side effects include:
Serious adverse events are uncommon. The drug is contraindicated in patients with known hypersensitivity to rebamipide.
The safety of rebamipide during pregnancy and breastfeeding has not been fully established. Use in these situations should only be considered after careful assessment of the benefit-risk ratio by the treating physician. Rebamipide is not officially approved in many European countries but may be used on an individual case basis.